Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
|
|
|
- Dwight French
- 7 years ago
- Views:
Transcription
1 Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de Oncología, Valencia, Spain Jan B. Vermorken Antwerp University Hospital, Edegem, Belgium
2 Scientific Committee Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
3 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March :30-08:45 Welcome 08:45-09:25 Keynote Lecture: Progress in the treatment of ovarian cancer. Lessons from Homologous Recombination Deficiency Stanley B. Kaye, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom SESSION - 1 CRITICAL ISSUES FOR FURTHER DEVELOPMENT IN OVARIAN CANCER Chairs: Douglas A. Levine, Memorial Sloan Kettering Cancer Center, New York (NY), USA Ignacio Romero, Fundación Instituto Valenciano de Oncología, Valencia, Spain 09:25-09:45 The molecular genetics of epithelial ovarian cancer Michael J. Birrer, Massachusetts General Hospital, Boston (MA), USA 09:45-10:05 Immunology Lana Kandalaft, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland 10:05-10:15 Discussion
4 SESSION - 2 INNOVATIONS IN THE APPROACH TO BORDERLINE TUMORS AND EPITHELIAL OVARIAN CANCER Chairs: Jonathan S. Berek, Sergi Martínez, Hospital Clínic Universitari, Barcelona, Spain 10:15-10:35 Molecular pathology of borderline tumors Anais Malpica, The University of Texas MD Anderson Cancer Center, Houston (TX), USA 10:35-10:55 Optimal approach to borderline tumors Andreas Du Bois, Kliniken Essen-Mitte, Essen, Germany 10:55-11:15 Molecular imaging in invasive ovarian carcinoma An Reyners, University Medical Center Groningen, Groningen, The Netherlands 11:15-11:35 Neoadjuvant chemotherapy in ovarian cancer revisited? Sven Mahner, University Medical Center Hamburg-Eppendorf, Hamburg, Germany 11:35-11:45 Discussion 11:45-12:15 Coffee break SESSION - 3 CLINICAL IMPACT OF TARGETED THERAPIES Chairs: Sandro Pignata, National Cancer Institute, Naples, Italy Andrés Poveda, Fundación Instituto Valenciano de Oncología, Valencia, Spain 12:15-12:35 Antiangiogenic agents Bradley J. Monk, St. Joseph s Hospital and Medical Center, Phoenix (AZ), USA 12:35-12:55 PARP inhibitors Jonathan A. Ledermann, University College London Cancer Institute, London, United Kingdom 12:55-13:15 Other targeted agents David R. Spriggs, Memorial Sloan Kettering Cancer Center, New York (NY), USA 13:15-13:30 Discussion 13:30-15:00 Lunch
5 SESSION - 4 DIFFERENTIATED APPROACH TO EPITHELIAL OVARIAN CANCER Chairs: Antonio González, MD Anderson Cancer Center, Madrid, Spain Isabelle Ray-Coquard, Centre Léon Berard, Lyon, France 15:00-15:20 Maintenance therapy in non-selected histotypes Jacobus Pfisterer, Gynecologic Oncology Center, Kiel, Germany 15:20-15:40 Low grade serous David M. Gershenson, The University of Texas MD Anderson Cancer Center, Houston (TX), USA 15:40-16:00 Clear cell tumors Keiichi Fujiwara, Saitama Medical University International Medical Center, Saitama, Japan 16:00-16:20 Mucinous tumors Timothy Perren, Leeds Institute of Cancer Medicine and Pathology, St James's University Hospital, Leeds, United Kingdom 16:20-16:30 Discussion 16:30-17:00 Coffee break SESSION - 5 STANDARD OF CARE OF OVARIAN CANCER IN 2015 Chairs: Andrés Cervantes, Hospital General Universitario, Va lencia, Spain Jan B. Vermorken, Antwerp University Hospital, Edeg em, Belgium 17:00-17:30 Primary disease Michael A. Bookman, University of Arizona Cancer Center, Tucson (AZ), USA 17:30-18:00 Recurrent disease Eric Pujade-Lauraine, Hôpital Hotel-Dieu, Paris, France 18:00-18:30 Patient reported outcomes in ovarian cancer clinical trials. Missed opportunities Michael Friedlander, The Prince of Wales Hospital, Randwick, Australia 18:30-18:45 Discussion 18:45-19:00 Remarks and conclusions Andrés Poveda, Fundación Instituto Valenciano de Oncología, Valencia, Spain
6 Venue Palau de la Música Iturbi Meeting Room Paseo de la Alameda, Valencia, Spain Language The official language of the symposium is English. Simultaneous translation into Spanish will be provided. Symposium secretariat
Wednesday, February 24 th, 2016
List of Faculty: Nadeem R. Abu-Rustum, Memorial Sloan Kettering Cancer Center. New York, USA Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy Natalia Carballo, David Cibula, General University
Wednesday, February 24 th, 2016
List of Faculty: Nadeem R. Abu-Rustum, Memorial Sloan Kettering Cancer Center. New York, USA Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy Natalia Carballo, David Cibula, General University
REVIEW ARTICLE. Key Words: CA 125, Ovarian cancer, Response, Progression, RECIST, Clinical trials
REVIEW ARTICLE Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG) Gordon John Sampson Rustin,
CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010
CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010 Organisers S. Gail Eckhardt, University of Colorado Denver, Aurora, USA Roy S. Herbst, The University of Texas MD Anderson
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
EMERGING THERAPIES IN GYNECOLOGICAL CANCER
MD ANDERSON INTERNATIONAL MEETING IN GYNECOLOGIC ONCOLOGY: EMERGING THERAPIES IN GYNECOLOGICAL CANCER Directors: Dr. Luis Chiva. Head of Department of Gynecologic Oncology. Dr. Antonio González-Martín.
October 22, 2014. October 23, 2014
Organizers Mercedes Robledo; José María de Campos; James Gnarra; Eric Jonasch Mª Elena Kusak; Susi Martinez; Ilene Sussman; Karina Villar Scientific Committee José María de Campos; Carlos Cenjor; Graeme
Promises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
CLINICAL ONCOLOGY MASTERCLASS IN. 25-29 April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME
ESO - LATIN-AMERICAN PROGRAMME MASTERCLASS IN CLINICAL ONCOLOGY 25-29 April 2015 São Paulo, Brazil Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT FOREWORD
Promises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN
D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.
Scientific Program Call for Abstracts Registration Accommodation
SECOND ANNOUNCEMENT Scientific Program Call for Abstracts Registration Accommodation Deadline for abstract submission: September 20 th, 2011 www.madridbreastcancer2011.com Madrid, November 16-17, 2011
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
Scientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region April 2016 27-30 Santiago - Chile Hotel Diego de Almagro San Pío X 2530, Providencia, Santiago. INFORMATION www.lungcancerworkshop.cl
30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
pulmonary hypertension bologna 2012 Royal Hotel Carlton - Bologna - Italy Under the aegis of alma mater studiorum università di bologna
Under the aegis of alma mater studiorum università di bologna dipartimento cardiovascolare pulmonary hypertension bologna 2012 Royal Hotel Carlton - Bologna - Italy November 23-24, 2012 Friday, november
Resolving Cancer Heterogeneity:
INTERNATIONAL SYMPOSIUM ON: Resolving Cancer Heterogeneity: The way to personalised medicine Palazzo della Gran Guardia Verona (Italy), June 30 th July 2 nd, 2016 PROGRAM Organized by: ARC-Net Centre for
13 May 14 May. SESSION 2.- Advances in hearing loss research II Chair: Andrew Forge
13 May 14 May 15:00-17:00 Registration 15:45-16:00 Welcome on behalf of the organizers José María Millán. Unit of Genetics La Fé Hospital. CIBERER. Valencia. Spain. 16:00-16:30 Francesc Palau. CIBERER
Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France 11-14 September 2008
33 rd European Symposium on Hormones and Cell Regulation Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers Mont Ste. Odile, Alsace, France 11-14 September 2008 Invited Speakers:
Gross Domestic Product (GDP-PPP) Estimates for Metropolitan Regions in Western Europe, North America, Japan and Australasia
Gross Domestic Product (GDP-PPP) Estimates for Metropolitan Regions in Western Europe, North America, Japan and Australasia Draft April 2007 GROSS DOMESTIC PRODUCT ESTIMATES: METROPOLITAN REGIONS In Western
ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN. 8-13 March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS
MASTERCLASS Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans 7 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 8-13 March 2014 Ermatingen
Gastrointestinal Tumors
Gastrointestinal Tumors CHAIRMEN: A. Carrato B. Massutí ORGANIZING COMMITTEE: A. Abad A. Antón E. Aranda A. Cervantes E. Díaz-Rubio M. Navarro J.M. Tabernero A. Carrato B. Massutí IX TTD International
ESO INSIDE TRACK CONFERENCE. 3 rd FAMILIAL CANCER CONFERENCE. 5-6 June 2008 Madrid, Spain MADRID. Chair: J.Benitez, ES - R. Eeles, UK - H.
ESO INSIDE TRACK CONFERENCE MADRID 3 rd FAMILIAL CANCER CONFERENCE 5-6 June 2008 Madrid, Spain Chair: J.Benitez, ES - R. Eeles, UK - H.Vasen, NL ABSTRACT SUBMISSION Poster abstract deadline 1 APRIL 2008.
Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy
Programme Invited Speakers: Reuven Agami (The Netherlands), Manuela Baccarini (Austria), Allan Balmain (USA), Daniel Birnbaum (France), Anne-Lise Børresen-Dale (Norway), Carlos Caldas (UK), Silvana Canevari
Ph.D. in Molecular Medicine
Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to
VIENNA. October 8 th -10 th 2012
VIENNA October 8 th -10 th 2012 Days of Molecular Medicine 2012 The Translational Science of Rare Diseases: From Rare to Care Dates: October 8 th, 9 th, 10 th, 2012 Venue: Garden Palace of the Liechtenstein
T u m o r D o r m a n c y
1 st O N COLille Symposium on T u m o r D o r m a n c y June 26, 2014 Lille, France Invited Speakers Julio Aguirre-Ghiso, Tisch Cancer Institute, New-York, USA Dormancy - Micrometastasis Marieke Essers,
The Management. 15 th December, VENICE Hotel Palazzo Giovanelli Santa Croce, San Stae, 2070. Workshop on
INTERNATIONAL CLUB OF ASCITES Workshop on The Management of Renal Dysfunction in Patients with Cirrhosis 14 th December, PADUA Aula Morgagni Policlinico Universitario Via Giustiniani 2 15 th December,
October 22, 2014. October 23, 2014
Organizers Mercedes Robledo; José María de Campos; Jesús García-Donas, James Gnarra; Eric Jonasch, Mª Elena Kusak; Susi Martinez; Ilene Sussman; Karina Villar Scientific Committee José María de Campos;
Learning, Memory and Cognitive Function Mechanisms, Pathology and Therapeutics
International Symposium on Learning, Memory and Cognitive Function Mechanisms, Pathology and Therapeutics February 10-12, 2008 Valencia, Spain PRELIMINARY PROGRAM Richard G. Morris. University of Edinburgh,
13 September 2016 - London, UK
INTERNATIONAL WORKSHOP PRELIMINARY PROGRAMME MS Academia: Multiple sclerosis advanced course 13 September 2016 - London, UK MS Academia - Multiple sclerosis advanced course Overview Multiple sclerosis
MS: from disease management to patient management
2012 CME Annual meeting in multiple sclerosis MS: from disease management to patient management Valencia, Spain 18-19 May 2012 Dear Colleague On behalf of the Serono Symposia International Foundation we
PULMONARY HYPERTENSION. This meeting is fully sponsored by GlaxoSmithKline and jointly organised with the Meeting Faculty and GlaxoSmithKline
F O C U S O N PULMONARY HYPERTENSION B O L O G N A 2 0 1 0 1 5 y e a r s o n... p r o g r a m June 24-26, 2010 - Bologna, Italy This meeting is fully sponsored by GlaxoSmithKline and jointly organised
Increasing Innovation in R&D - Seizing early stage external growth opportunities
Increasing Innovation in R&D - Seizing early stage external growth opportunities Paul R. Eynott, PhD sanofi-aventis, US paul.eynott@sanofi-aventis.com -1- Sommaire -2- CHRISTOPHER A. VIEHBACHER Chief Executive
International Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
Data from an interim analysis from the pivotal Phase 3 trial of YONDELIS in soft tissue sarcoma, SAR-3007, will be presented in an oral presentation
PharmaMar announces new advances in oncology at ASCO 2015 for its compounds YONDELIS and PM1183 in small cell lung cancer, soft tissue sarcoma, and mesothelioma Compelling clinical activity of PM1183 in
Targeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
POST-CONGRESS SATELLITE MEETINGS May 24 th, 2013. Cancer biomarkers 2013
20 th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine 45 th Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) POST-CONGRESS SATELLITE
Departments of Nuclear Medicine, Surgery, and Endocrinology University of Ulm
4 th Würzburg Summer School of Thyroid Cancer Management A training course on basics, diagnosis and therapy of differentiated thyroid tumours under the auspices of the European Association of Nuclear Medicine
Regional Young Investigator SIC meeting. 5-6 March 2015
Regional Young Investigator SIC meeting 5-6 March 2015 Aula Magna A - Università Magna Graecia di Catanzaro - Campus Universitario S. Venuta Viale Europa, loc. Germaneto - Catanzaro Invited speakers: Rita
INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY 19-20 June 2015
LS LS Magna Gr ae cia University of Catanzaro, Italy Preliminary Program PhD PROGRAMME PhD PROGRAMME MOLECULAR AND TRANSLATIONAL ONCOLOGY LIFE SCIENCES ORGANIZING COMMITTEE Professor Ennio Carbone Head
9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium
9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) Szeged,
Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center
(last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical
Ovarian Cancer. December 2 3, 2011. The 9th International Conference on
The 9th International Conference on Ovarian Cancer December 2 3, 2011 The University of Texas Cancer Center 8th Floor Conference Center Cancer Prevention Building 1155 Pressler, Houston, Texas The 9th
Stem cells: the diverging goals of regenerative medicine and oncology ROME JULY 1-2, 2010 CALL FOR ABSTRACTS
Preliminary Programme INTERNATIONAL CONFERENCE Promoted by: Consiglio Nazionale delle Ricerche In collaboration with Stem cells: the diverging goals of regenerative medicine and oncology CHAIRMEN: KENNETH
New Directions in Treatment of Ovarian Cancer. Amit M. Oza Princess Margaret Hospital University of Toronto
New Directions in Treatment of Ovarian Cancer Amit M. Oza Princess Margaret Hospital University of Toronto Newly diagnosed: scenario Ist line Surgery chemotherapy Cure If can t cure can we turn into chronic
Scientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo The University of Texas, MD Anderson
Section 1. Section 2. 2.1. Venue... 6 2.2. Registration. 6 2.3. Acknowledgement of Funding... 6. V: 04.04.16 1 of 6
PROGRAMME 18 th 19 th April 2016 Freiburg, Germany Contents Section 1 1.1. Foreword from Dr Valayannopoulos, Chair, ETAC.. 2 1.2. Learning Objectives 2 1.3. Organising Committee 3 1.4. Faculty Members...
Best of San Antonio Breast Cancer Symposium
Best of San Antonio Breast Cancer Symposium 11:45 am - 5:00 pm 5800 Rockside Woods Blvd. About the Course The San Antonio Breast Cancer Symposium is an international meeting of laboratory and clinical
PROGRAM GENETIC AND EPIGENETIC ANALYSES OF HUMAN EMBRYOS: PAST, PRESENT AND FUTURE
PROGRAM Thursday, September 17 h 15.00 I SESSION GENETIC AND EPIGENETIC ANALYSES OF HUMAN EMBRYOS: PAST, PRESENT AND FUTURE Chairmen: Carlo Flamigni (Bologna, Italy) - Sebastiano Bianca (Catania, Italy)
Madrid International Bariatric Endoscopy
2 nd international course Madrid International Bariatric Endoscopy www.mibemeeting.com MIBE 2015 Madrid International Bariatric Endoscopy 24 th and 25 th 2015 September Madrid Sanchinarro University Hospital
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
Interna'onal congress on Cancer cell death and resistance
! Interna'onal congress on Cancer cell death and resistance May 6 and 7, 2013 h"p://kcelldeath.sciencesconf.org Golf of Seilh Near to Toulouse (Midi-Pyrénées, 31, France) Introduction Content : ² Introduction
Belgium Ghent University, Ghent Rigshospitalet, Copenhagen. Denmark. Germany UniversitätKlinikum, Essen Heidelberg University Hospital, Heidelberg
We are ready to actively participate in the development of innovative therapies that will improve the cure rate and quality of life of children with cancer. Created in 2003, ITCC is a consortium of 49
Advances in Biology and Treatment of Malignant Brain Gliomas
Advances in Biology and Treatment of Malignant Brain Gliomas International Congress 2 nd Edition Rome, June 12-13, 2014 President Giulio Maira Vice Presidents Ruggero De Maria, Antonio Iavarone, Angelo
TEACH Summer School Cascais, Portugal 3-7 July, 2016. Training and Education for Advanced Clinicians and HCPs in Personalised Medicine
TEACH Summer School Cascais, Portugal 3-7 July, 2016 Training and Education for Advanced Clinicians and HCPs in Personalised Medicine TEACH Summer School Cascais, Portugal 3-7 July, 2016 Objectives There
Hereditary Angioedema WorKing group HAWK 2012 Consensus Meeting Angioedema without wheals: classification and diagnosis
Hereditary Angioedema WorKing group HAWK 2012 Consensus Meeting Angioedema without wheals: classification and diagnosis Palazzo Feltrinelli, Gargnano del Garda (Brescia), Italy September 30 th - October
JUNE 2-3, 2014 CONNECT.
JUNE 2-3, 2014 CONNECT. GROW. SUCCEED. THIRD INDUSTRIAL CELL CULTURE TECHNOLOGY CONFERENCE JUNE 2-3, 2014 Laupheim s historical castle, Schloss Großlaupheim, Germany Rentschler Biotechnologie GmbH is delighted
2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer
REVIEW ARTICLE 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer Report From the Fourth Ovarian Cancer Consensus Conference Gavin C.E. Stuart, MD, FRCSC,*
Program Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change
FRIDAY, FEBRUARY 20, 2015 Program Chairs: and Martin Martino, MD Speakers and times are subject to change 6:00 a.m. 6:00 p.m. Registration/Information Desk /L Foyer 6:00 a.m. 6:00 p.m. Speaker Ready Area
Houston Cancer Institute
Houston Cancer Institute A personal path to healing Memorial-West Houston Katy Northwest Houston Southeast Houston Sugar Land Convenience for Patients State of the Art Therapies and Diagnosis Real Support
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
Inditex Group first-half net sales up 17%
16 September 2015 FIRST-HALF 2015 RESULTS Inditex Group first-half net sales up 17% Net sales totalled 9.42 billion, while net profit rose 26% year-on-year to 1.16 billion In the past twelve months, Inditex
The PSA Controversy: Defining It, Discussing It, and Coping With It
The PSA Controversy: Defining It, Discussing It, and Coping With It 11 TH ANNUAL SYMPOSIUM ON MEN S HEALTH June 12, 2013 The PSA Controversy Defining It, Discussing It and Coping With It As of May 2012,
BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C
Symposium of the Swiss-Austrian ISOP Chapter International Society of Pharmacovigilance BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C Program: Thursday,
Curriculum Vitae - Sara Gandini
Curriculum Vitae - Sara Gandini Academic information 2004 PHD IN CANCER STUDIES at the University of Birmingham (Public Health), UK. Thesis: Meta-Analysis in Cancer Epidemiology. 1995 MASTER OF SCIENCE
ENVISIONING THE FUTURE OF DERMATOLOGY THROUGH THE LENS OF MEDICAL INFORMATICS
Is pleased to announce: ENVISIONING THE FUTURE OF DERMATOLOGY THROUGH THE LENS OF MEDICAL INFORMATICS CONFERENCE LOCATION MEMORIAL SLOAN KETTERING CANCER CENTER ROCKEFELLER RESEARCH LABORATORIES BOARD
QUANTITATIVE APPROACHES IN CELL BIOLOGY BIOPHYSICS, BIOENGINEERING & SYSTEMS BIOLOGY
QUANTITATIVE APPROACHES IN CELL BIOLOGY BIOPHYSICS, BIOENGINEERING & SYSTEMS BIOLOGY SignGene Symposium 2014 August 31 - September 2, 2014 Max Delbrück Center for Molecular Medicine Berlin, Germany www.mdc-berlin.de/signgenesymposium2014
UNIVERSITY TOP 50 BY SUBJECTS a) Arts and Humanities Universities 2011-2012
Times Higher Education s World University Rankings UNIVERSITY TOP 50 BY SUBJECTS a) Arts and Humanities Universities 2011-2012 Top 50 Arts and Humanities Universities 2011-2012 1 Stanford University United
The Texas Biotechnology Industry
The Texas Biotechnology Industry 2014 Fortune 1000 company NBTY opens state-of-the-art vitamin manufacturing plant in San Antonio See Page 15 Allergan installs new production line at Waco pharmaceutical
Item 7: Projects. Clair Watts Francoise Charnay-Sonnek
Item 7: Projects Clair Watts Francoise Charnay-Sonnek Re-structuring Exec Board Working groups Com Adv Res Ed Advisory Council Executive Office Task Groups General Assembly Database Working Group Chairs
Master Online Study Program @dvanced Oncology. Study part time team up internationally!
Master Online Study Program @dvanced Oncology Study part time team up internationally! Ulm University is developing an innovative international postgraduate study program @dvanced Oncology addressing clinical
NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES
PRESS RELEASE NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES European research centres in life sciences gather to foster excellence in research, share knowledge, and influence
EMBL. International PhD Training. Mikko Taipale, PhD Whitehead Institute/MIT Cambridge, MA USA
EMBL International PhD Training Mikko Taipale, PhD Whitehead Institute/MIT Cambridge, MA USA Why create an EMBL? The structure of DNA had been solved and first protein structures were being identified
ACCORD PROJECT FINAL RESULTS OF THE. 2 nd June, 2015. Rafael Matesanz, on behalf of the ACCORD consortium. Director
FINAL RESULTS OF THE ACCORD PROJECT 2 nd June, 2015 Auditorium MUTUA MADRILEÑA Foundation, MADRID Director Rafael Matesanz, on behalf of the ACCORD consortium Achieving Comprehensive Coordination in Organ
ANNUAL MEETING ISTANBUL - TURKEY. November 18-19, 2011 Istanbul University Beyazıt Campus. ECNM European Competence Network on Mastocytosis
ISTANBUL - TURKEY Thursday, November 17: Arrival SCIENTIFIC PROGRAM 19.00 Welcome Reception (for the speakers at Doubltree by Hilton Hotel in Bayezit, Istanbul) Friday, November 18 08:30 Welcome Coffee
Market Highlights Miami
Market Highlights Miami Highest Number of Sales In Miami s 93 Year History 2011 2012 2013 Could be another! April News Headlines: Miami Condo Sales Spiked 18.7% with Luxury Properties Leading the Pack
URO. 19/20 March 2015. 4 th International Workshop. Madrid
URO 2015 4 th International Workshop ADVANCED PROSTHETIC UROGENITAL SURGERY IN THE TREATMENT OF POST-RADICAL PROSTATECTOMY SEQUELAE Madrid 19/20 March 2015 Puerta de Hierro-Majadahonda University Hospital
International Symposium on Stem Cell Research November 12 to 14, 2009 Buenos Aires, Argentina
International Symposium on Stem Cell Research November 12 to 14, 2009 Buenos Aires, Argentina Organizer: Ministry of Science, Technology and Productive Innovation of Argentina Sponsor: International Society
INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES
Since breast cancer is not a systemic disease from inception, when the imagers find in situ and 1-14 mm invasive breast cancer, it is the surgeon, specialized in the treatment of breast diseases, who should
How To Raise Money For Rare Cancer Research
Our 2014 Impact Funding Allocations Cycle for Survival funds promise: Our donations launch and accelerate research studies and clinical trials that drive discovery. By helping fill the funding gap in rare
INTRODUCTION TO THE PRACTICE OF AMERICAN MEDICINE. Introduction to the Practice of American Medicine
INTRODUCTION TO THE PRACTICE OF AMERICAN MEDICINE Introduction to the Practice of American Medicine IPAM A two-day workshop designed to prepare candidates to apply for medical residency training in the
Selecting Second Line Treatment for Relapsing Epithelial Ovarian Cancer. Dr. Rebecca Kristeleit Prof. Jonathan Ledermann UCL, London, UK
Selecting Second Line Treatment for Relapsing Epithelial Ovarian Cancer Dr. Rebecca Kristeleit Prof. Jonathan Ledermann UCL, London, UK Overview of Presentation This presentation will discuss the management
6th International Congress of Baltic Medico-Legal Association. New Technologies in Forensic Medicine Vilnius, Lithuania, Closing remarks
6th International Congress of Baltic Medico-Legal Association New Technologies in Forensic Medicine Vilnius, Lithuania, Closing remarks June 14-16, 16, 2007 Vilnius, Lithuania 6 BMLA Congress 2007 Vilnius
Temario- speakers. Management of the axilla in local and / or regional recurrence Manejo de la axila en la recurrencia local y / regional.
16.08.11 Henry Kuerer MD, PhD, FACS Director Breast SurgicalOncology University of Texas MD Anderson Cancer Center. Houston, TX Re-excision in local recurrence after conservative therapy Retumorectomía
Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2228475/ Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 Description: Avastin (Renal Cell Carcinoma) Analysis and
Curriculum Vitae. Luci A. Power. Education: M.S. Hospital Pharmacy, 1977 Northeastern University, Boston, Massachusetts
Curriculum Vitae Luci A. Power Education: M.S. Hospital Pharmacy, 1977 Northeastern University, Boston, Massachusetts Licensure: California, 1978 Experience: B.S. Pharmacy, 1969 Northeastern University,
Cellular, Molecular, and Biochemical Targets in Breast Cancer
Cellular, Molecular, and Biochemical Targets in Breast Cancer Kristy Kummerow Ingrid Meszoely December 12, 2012 VUMC Resident Bonus Conference One size fits all surgical treatment of breast cancer Wilhelm
Nuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
COMPENDIA TRANSPARENCY TRACKING FORM. Ovarian cancer, recurrent
COMPENDIA TRANPARENCY TRACKING FORM DRUG: Pemetrexed INDICATION: Ovarian cancer, recurrent COMPENDIA TRANPARENCY REQUIREMENT 1 Provide criteria used to evaluate/prioritize the request (therapy) 2 Disclose
2015 Global Online Fellowship In Head & Neck Surgery and Oncology
2015 Global Online Fellowship In Head & Neck Surgery and Oncology The Fellowship There are no current global standards of training, practice and level of care for patients with neoplasms of the Head and
The EBMT Cellular Therapy and Immunobiology Symposium
The EBMT Cellular Therapy and Immunobiology Symposium From Transplantation to Gene Therapy: Cellular therapy in evolution November 11 th -13 th, 2015 San Raffaele Scientific Institute Chairman Dr. Chiara
Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University Magnetic
Group 1 Group 2 Group 3 Group 4
Open Cities Lesson 1: Different kinds of cities Worksheet Task 1 Find the countries on the map Group 1 Group 2 Group 3 Group 4 1 Austria 2 Belgium 3 Bulgaria 4 Cyprus 5 Czech Republic 6 Denmark 7 Estonia
FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.
INSIDE TRACK CONFERENCE ESO, CNIO AND NRCO CONFERENCE ON FAMILIAL CANCER 19-20 May 2016 Madrid, Spain Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. Vasen, NL FOREWORD The ESO, CNIO and NRCO Conference
Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015
Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015 Place: Lecture Hall EKEN, Entrance 65, CAMPUS US, The Faculty of Medicine and Health Science, Linköping University,
Preliminary Program 9th EDS Postgraduate Course Riga, Latvia May 14-16, 2015
Preliminary Program 9th May 14-16, 2015 Venue: Riga city Bellevue Park Hotel Riga, Slokas iela 1, Rīga, Latvia Thursday, May 14, 2015 Time 14:00-14:20 Workshop: Evidence Based Medicine (limited to 35 participants)